Paten. The deaths occurred within a 10 day period not on one day. 10 days is a long spam of time. Could it be that Freisius, did not immediately communicate with their other clinics regarding the death and they continued I don't know. Kinda hard to believe but it gives me a little pause. I'll let ya know Paten if I go long.
Max thanks for the post as always. I was thinking about item 7 which reads as follows:
7. All 5 deaths occurred at Fresenius' clinics. ALL in the first 10 days and ALL on first dosage. ALL OTHERS OF THE 25000 TOTAL PATIENTS were NOT fatal, and there was a distribution of known side effects comparable and approximate % to those experienced during the clinical trials.
Max I try to put myself in the shoes of Fresenius.
If I am the CEO or Officer of this company the minute someone died in one of my clinics, with an apparent reaction to a new drug, the first thing "I" would do is to cease administering the drug immediately, at all clinics the minute I was informed of one single death.
Not one additional patient would be given "O" until I was absolutely convinced that proper procedures were taken, as directed by the label, on the first deceased patient.
That is what has me confused and caused me to be a little hesitant to start a position.
If you have any answers for this concern please let me know as you know I have always respected you over on the QCOR Board.
Paten..still debating but if I do I will go in with the thought of losing my entire investment. This drug "O" is scheduled to go before the EMA European FDA in a few weeks. I'm curious to see what they do as far as approving after what has happened here in the US.
paten..I might be wrong on this but from reading on the AFFY board,my understanding is that the deaths occurred at different places but they were all owned by Frenisius a major dialysis company. Another thing I read was all the instances occurred on the first day of administration of the drug. Or in other words first time users. Seems to support AFFYs point...But JMO.
If you have a family to feed the last place you need to be is in the stock market, especially in a bio-tech stock.
If Qcor does not buy back a SIGNIFICANT number of shares this Qtr I will have to re-think, unless they have a very good reason.
patenright. yesterday when I said I was waiting to see what qcor did at the 20dma my chart showed the 20dma @34.95...I check it this morning and it shows the 20dma to be @35.25 Thanks
I was going to make a smart remark about "communication strategies" but I won't get that going again...Good Luck everyone...Buyin the dips.